AP
Amphastar P
🇺🇸XNAS.AMPHUnited StatesHealthcare
$23.70USDup +0.03 (+0.13%)OpenDelayed2:27 PM
Price$23.70+0.03 (+0.13%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US03209R1032
- CUSIP
- 03209R103
Company
- Employees
- 1,976
- Headquarters
- Rancho Cucamonga, United States
- Website
- https://www.amphastar.com
- CEO
- Dr. Yongfeng Zhang Ph.D.
Market
- Shares outstanding
- 42.5M
- Market cap
- $1.01B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $1.01B
- EPS LTM
- $1.78
- P/E LTM
- 11.37
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $730.02M+1.35%up year on year
- Net income
- $78.55M-41.69%down year on year
- Gross margin
- 47.68%-4.68%down year on year
- Free cash flow
- $152.89M+36.28%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.